Hereditary Hemorrhagic Telangiectasia: Vascular Biology
and Pathophysiology

Workshop Presentation Slides

June 8 Presentations

• Transforming growth factor-β pathway and HHT
  Carmelo Bernabeu, Ph.D.
  Centro Investigaciones Biológicas, CSIC
  
  
• Genetic variation in TGFβ1 dependency for vascular development
  Rosemary J. Akhurst, Ph.D.
  University of California, San Francisco
  Mt. Zion Cancer Research Institute
  
  
• BMP9 is a potent activator of ALK1 signalling in endothelial cells
  Sabine Bailly, Ph.D.
  INSERM
  
  
• Vascular Biology and HHT
  Michelle Letarte, Ph.D.
  The Hospital for Sick Children
  
  
• Alk1 signaling favors resolution in the zebrafish endothelium
  Beth Roman, Ph.D.
  Georgetown University Medical Center
  
  
• Endoglin has a crucial role in blood cell-mediated vascular repair
  Linda W. van Laake
  Hubrecht Laboratory
  Netherlands Institute for Developmental Biology
  
  
• Endothelial Biology of PAH and HHT: A "Genotype"-Phenotype Assessment
  Duncan John Stewart, M.D.
  St. Michael's Hospital
  University of Toronto
  
  
• Endothelial O-glycans are essential for angiogenesis
  Lijun Xia
  Oklahoma Medical Research Foundation
  
  
• Characterization of Endothelial cells from Hereditary Haemorrhagic Telangiectasia patients
  Africa Fernandez-Lopez
  Centro Investigaciones Biológicas, CSIC
  
  
• Small Molecules and Chemical Genomics: Tools for Understanding HHT?
  Christopher Austin, M.D.
  National Human Genome Research Institute
  National Institutes of Health

June 9 Presentations

• Organ Pathophysiology The Human Model
  Marie E. Faughnan, M.D., M.S.C.
  St. Michael's Hospital
  
  
• Abnormal Development of Retinal Vasculature and Retinal Neovascularization During Oxygen-Induced Ischemic Retinopathy in Endoglin Heterozygous Mice
  Nader Sheibani, Ph.D.
  University of Wisconsin

All presentation slides are in format. To view, download the free Adobe Reader.

Top of page

Last Reviewed: April 4, 2011

Print